...Biotechs created or co-founded by Truffle include antiviral play Abivax S.A. (Euronext: ABVX), antibiotics company Deinove S.A....

...Researchers from Technical University Berlin and the Deinobiotics subsidiary of Deinove S.A. (Euronext:ALDEI) identified a new class...
...to further investigate the compounds' mechanism of action to develop them as antimicrobial drugs. Elizabeth S. Eaton Deinobiotics Deinove S.A. Technical...

...from the Deinococci bacteria. Deinove, which owns 49% of Deinobiotics, granted the subsidiary rights to Deinove's...
...Deinove has the option to buy back all Deinobiotics shares sold to the holding company. Deinove...
...is the founder of Novoxel, which AstraZeneca plc (LSE:AZN; NYSE:AZN, London, U.K.) acquired in 2010. Deinove S.A....

...Deinococcus bacteria. The milestone was triggered by the selection of a thermophilic Deinococcus base strain. Deinove...
...under the deal so far, is eligible for about €2.6 ($3.7 million) in additional milestones. Deinove S.A....

...Inc. (NASDAQ:ALIM) 4/22/10 $72.1 $341.6 $231.0 -32% Codexis Inc. (NASDAQ:CDXS) 4/22/10 $78.0 $441.7 $297.6 -33% Deinove S.A....

...autoimmune and inflammation company Neovacs S.A. raised 10 million ($13.6 million) followed by bioprocessing play Deinove S.A....

...Bioprocessing play Deinove S.A. is the second biotech in as many weeks to go public on Alternext...
...which became the home of small companies with little financial or research momentum. Last week, Deinove...
...is doing reasonably well as a market with liquidity," he said. As for Neovacs and Deinove...